Navigation Links
Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution

PHILADELPHIA, June 25, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.

Cortellis for Regulatory Intelligence is a comprehensive regulatory solution  that  helps regulatory affairs professionals make timely and more informed decisions by providing them with exclusive regulatory information for multi-country filings, comparing existing and emerging competitive products, preparing for committee meetings and inspections, and keeping up-to-date on regulatory changes as they happen.

"Our business depends on understanding the global regulatory landscape and the continually evolving submission approval requirements," said Rick Riegel, CEO of Liquent. "By using Cortellis for Regulatory Intelligence, we can assure our clients that our knowledge is supplemented by the industry's leading regulatory intelligence database.  In addition, it provides the opportunity to explore new ways of incorporating that knowledge into our own solutions via the available API's in the Cortellis platform."

This new regulatory intelligence solution enables companies to more quickly and easily leverage the comprehensive and enhanced regulatory content via Thomson Reuters Cortellis™, the premiere Life Sciences platform.

Cortellis delivers impressive search speeds and more relevant results due to an all-new search engine in a highly intuitive user interface. The search engine allows for rapid free-text searching, making it possible for users to search across the platform's entire regulatory database without the need to design complex search strategies, while custom filters are available to increase accuracy. Cortellis will also make valuable information more accessible and is compatible with mobile devices, including smartphones and tablet devices, providing a more interactive user experience, and the freedom to stay informed while on the go.

Here is what some pharmaceutical professionals have said after using Cortellis for Regulatory Intelligence:

  • "Cortellis for Regulatory Intelligence is 'remarkably' different in a good way."
  • "This search platform is so different compared to standard IDRAC, it's almost incomparable! I think I will use it in a completely different way. Very nice!"
  • "We have explored Cortellis for Regulatory Intelligence and we are very pleased with the easy sorting capabilities."

"We are very excited to announce the launch of Cortellis for Regulatory Intelligence and think it has the power to transform the way the industry approaches and utilizes pharmaceutical regulatory intelligence," said Jon Brett-Harris, executive vice president of Life Sciences at Thomson Reuters. "The industry's needs for accessing regulatory intelligence are changing and Thomson Reuters is responding to the new demands. Cortellis for Regulatory Intelligence not only allows our customers to make stronger, better informed decisions, but will greatly improve their ability to be compliant."

To learn more about Cortellis for Regulatory Intelligence, visit or stop by our booth, #3001, at the DIA Annual Meeting between June 24 - 28.

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. For more information, go to

SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Thomson Reuters Finds Increase in New Research for Neglected Tropical Diseases
3. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
4. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
5. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
6. Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
7. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
8. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
9. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):